CuraGen Corporation - Pharmaceuticals & Healthcare - Deals and Alliances ProfileSummaryCuraGen Corporation, a biopharmaceutical development company is engaged in the research, development and commercialization of novel therapeutics used for the treatment of cancer. The company intends to advance its cancer treatments belinostat and CR011-vcMMAE, by means of clinical development. Its two products include CR011-vcMMAE, for the treatment of metastatic melanoma, breast cancer, and brain tumors, while CR014-vcMMAE is for the treatment of ovarian cancer and renal cell carcinoma. It also maintains a portfolio of early stage assets, including proteins, antibodies and small molecules for the treatment of cancer. The company is headquartered at Brandford, Connectticut, United StatesGlobal Market Direct's CuraGen Corporation - Pharmaceuticals & Healthcare - Deals and Alliances Profile is an essential source for company data and information. The profile examines the company's key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy as well as highlighting the company's major recent financial deals. Scope- Provides key company information for business intelligence needs- Gives information on the company's major recent financial deals including Mergers and Acquisitions, asset transactions, PE/VC deals, equity offerings, debt offerings and partnerships. - Data is supplemented with details on the company's history, key executives, business description, locations and subsidiaries as well as a list of products and services and the latest available company statement.Reasons to buy- A quick 'one-stop-shop' to understand the company.- Support sales activities by understanding your customers' businesses.- Qualify prospective partners and suppliers.- Understand and respond to your competitors' business structure, strategy and prospects through.- Understanding the key deals which have shaped the company.

1. Find Industry reports, Company profiles
ReportLinker and Market Statistics
>> Get this Report Now by email!
CuraGen Corporation - Pharmaceuticals & Healthcare - Deals and
Alliances Profile
Published on July 2009
Report Summary
CuraGen Corporation - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Summary
CuraGen Corporation, a biopharmaceutical development company is engaged in the research, development and commercialization
of novel therapeutics used for the treatment of cancer. The company intends to advance its cancer treatments belinostat and
CR011-vcMMAE, by means of clinical development. Its two products include CR011-vcMMAE, for the treatment of metastatic
melanoma, breast cancer, and brain tumors, while CR014-vcMMAE is for the treatment of ovarian cancer and renal cell carcinoma. It
also maintains a portfolio of early stage assets, including proteins, antibodies and small molecules for the treatment of cancer. The
company is headquartered at Brandford, Connectticut, United States
Global Market Direct's CuraGen Corporation - Pharmaceuticals & Healthcare - Deals and Alliances Profile is an essential source for
company data and information. The profile examines the company's key business structure and operations, history and products, and
provides summary analysis of its key revenue lines and strategy as well as highlighting the company's major recent financial deals.
Scope
- Provides key company information for business intelligence needs
- Gives information on the company's major recent financial deals including Mergers and Acquisitions, asset transactions, PE/VC
deals, equity offerings, debt offerings and partnerships.
- Data is supplemented with details on the company's history, key executives, business description, locations and subsidiaries as well
as a list of products and services and the latest available company statement.
Reasons to buy
- A quick 'one-stop-shop' to understand the company.
- Support sales activities by understanding your customers' businesses.
- Qualify prospective partners and suppliers.
- Understand and respond to your competitors' business structure, strategy and prospects through.
- Understanding the key deals which have shaped the company.
Table of Content
Table Of Contents
Table Of Contents 2
List of Tables 3
CuraGen Corporation - Pharmaceuticals & Healthcare - Deals and Alliances Profile Page 1/5

2. Find Industry reports, Company profiles
ReportLinker and Market Statistics
List of Figures 3
CuraGen Corporation, Pharmaceuticals & Healthcare, Deals By Year, 2004 to YTD 2009 4
CuraGen Corporation, Pharmaceuticals & Healthcare Deals By Type, 2004 to YTD 2009 5
CuraGen Corporation, Pharmaceuticals & Healthcare, Deals By Region, 2004 to YTD 2009 6
CuraGen Corporation, Pharmaceuticals & Healthcare, Deals By Sector, 2004 to YTD 2009 7
CuraGen Corporation, Pharmaceuticals & Healthcare, Deals Summary, 2004 to YTD 2009 8
CuraGen Corporation, Pharmaceuticals & Healthcare, Deal Details 9
Acquisition 9
Celldex Therapeutics To Acquire CuraGen 9
CuraGen Issues Convertible Subordinated Notes For $110 Million 10
Divestiture - Assets 11
CuraGen Sells Belinostat To TopoTarget 11
Divestiture - Company 12
Roche Acquires 454 Life Sciences From CuraGen 12
Equity Offering 13
CuraGen Completes Public Offering Of $22 Million 13
Partnerships 14
CuraGen and TopoTarget Announce the Grant of License to LEO Pharma 14
CuraGen Amends Its Agreement With Bayer Pharmaceuticals 15
CuraGen Signs Agreement With Broad Institute 16
CuraGen And TopoTarget Extends Agreement With National Cancer Institute 17
Seattle Genetics And CuraGen Expands Collaboration Agreement 18
CuraGen And TopoTarget Signs Agreement With National Cancer Institute 19
CuraGen Signs License Agreement With Seattle Genetics 20
CuraGen Signs Co-Development Agreement With TopoTarget 21
Key Competitors 22
Key Employees 22
Locations And Subsidiaries 22
Head Office 22
Appendix 23
Methodology 23
About Global Markets Direct 23
Contact Us 23
Disclaimer 23
List of Tables
CuraGen Corporation, Pharmaceuticals & Healthcare, Deals By Year, 2004 to YTD 2009 4
CuraGen Corporation, Pharmaceuticals & Healthcare Deals By Type, 2004 to YTD 2009 5
CuraGen Corporation, Pharmaceuticals & Healthcare, Deals By Region, 2004 to YTD 2009 6
CuraGen Corporation, Deals By Sector, 2004 to YTD 2009 7
CuraGen Corporation, Pharmaceuticals & Healthcare, Deals Summary, 2004 to YTD 2009 8
Celldex Therapeutics To Acquire CuraGen 9
CuraGen Issues Convertible Subordinated Notes For $110 Million 10
CuraGen Sells Belinostat To TopoTarget 11
Roche Acquires 454 Life Sciences From CuraGen 12
CuraGen Completes Public Offering Of $22 Million 13
CuraGen and TopoTarget Announce the Grant of License to LEO Pharma 14
CuraGen Amends Its Agreement With Bayer Pharmaceuticals 15
CuraGen Signs Agreement With Broad Institute 16
CuraGen And TopoTarget Extends Agreement With National Cancer Institute 17
Seattle Genetics And CuraGen Expands Collaboration Agreement 18
CuraGen Corporation - Pharmaceuticals & Healthcare - Deals and Alliances Profile Page 2/5

3. Find Industry reports, Company profiles
ReportLinker and Market Statistics
CuraGen And TopoTarget Signs Agreement With National Cancer Institute 19
CuraGen Signs License Agreement With Seattle Genetics 20
CuraGen Signs Co-Development Agreement With TopoTarget 21
CuraGen Corporation, Key Employees 22
List of Figures
CuraGen Corporation, Pharmaceuticals & Healthcare, Deals By Year, 2004 to YTD 2009 4
CuraGen Corporation, Pharmaceuticals & Healthcare, Deals by Type, 2004 to YTD 2009 5
CuraGen Corporation, Pharmaceuticals & Healthcare, Deals By Region, 2004 to YTD 2009 6
CuraGen Corporation, Pharmaceuticals & Healthcare, Deals by Sector, 2004 to YTD 2009 7
CuraGen Corporation - Pharmaceuticals & Healthcare - Deals and Alliances Profile Page 3/5

4. Find Industry reports, Company profiles
ReportLinker and Market Statistics
Fax Order Form
To place an order via fax simply print this form, fill in the information below and fax the completed form to:
Europe, Middle East and Africa : + 33 4 37 37 15 56
Asia, Oceania and America : + 1 (805) 617 17 93
If you have any questions please visit http://www.reportlinker.com/notify/contact
Order Information
Please verify that the product information is correct and select the format(s) you require.
CuraGen Corporation - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Product Formats
Please select the product formats and the quantity you require.
Digital Copy--USD 250.00 Quantity: _____
Contact Information
Please enter all the information below in BLOCK CAPITALS
Title: Mr Mrs Dr Miss Ms Prof
First Name: _____________________________ Last Name: __________________________________
Email Address: __________________________________________________________________________
Job Title: __________________________________________________________________________
Organization: __________________________________________________________________________
Address: __________________________________________________________________________
City: __________________________________________________________________________
Postal / Zip Code: __________________________________________________________________________
Country: __________________________________________________________________________
Phone Number: __________________________________________________________________________
Fax Number: __________________________________________________________________________
CuraGen Corporation - Pharmaceuticals & Healthcare - Deals and Alliances Profile Page 4/5

5. Find Industry reports, Company profiles
ReportLinker and Market Statistics
Payment Information
Please indicate the payment method, you would like to use by selecting the appropriate box.
Payment by credit card Card Number: ______________________________________________
Expiry Date __________ / _________
CVV Number _____________________
Card Type (ex: Visa, Amex…) _________________________________
Payment by wire transfer Crédit Mutuel
RIB : 10278 07314 00020257701 89
BIC : CMCIFR2A
IBAN : FR76 1027 8073 1400 0202 5770 189
Payment by check UBIQUICK SAS
16 rue Grenette – 69002 LYON, FRANCE
Customer signature:
Please note that by ordering from Reportlinker you are agreeing to our Terms and Conditions at
http://www.reportlinker.com/index/terms
Please fax this form to:
Europe, Middle East and Africa : + 33 4 37 37 15 56
Asia, Oceania and America : + 1 (805) 617 17 93
CuraGen Corporation - Pharmaceuticals & Healthcare - Deals and Alliances Profile Page 5/5